Waterloo, N2K 0A7, ON,
Canada
Blackberry
Blackberry, a prominent reseller, system integrator, and consulting company, that plays a vital role in numerous system integration and digital transformation initiatives. Blackberry collaboration with software players such as In-House Applications, OneBio and empowers organizations to embrace disruptive technologies and accelerate their journey to the cloud, thus reshaping their business models.
| Reseller and SI | Vendor | Application | Category | Market |
|---|---|---|---|---|
| Blackberry | In-House Applications | In-House Blockchain | Blockchain Platform | Blockchain |
| Blackberry | OneBio | OneBio Blockchain Platform | Blockchain Platform | Blockchain |
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Product | Category | When | Insight |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
Blackberry | Manufacturing | 1820 | $534M | Canada | In-House Applications | In-House Blockchain | Blockchain Platform | 2018 |
In 2018, BlackBerry implemented an In-House Blockchain as a Blockchain Platform to create an ultra-secure storage and sharing ecosystem for healthcare data, leveraging the company reputation for security as it expanded into regulated sectors such as healthcare and the Internet of Things. The implementation of the In-House Blockchain was positioned alongside BlackBerry enterprise offerings to address medical data flows from endpoints to laboratories and diagnostic services.
The deployment architecture centers on using BlackBerry network operating center resources to power the ONEBIO blockchain service, with functional capabilities focused on encrypted data storage, anonymization workflows, and controlled data exchange. The solution design emphasizes collection pipelines from patient devices, laboratories, and IoT biometric devices, and includes data anonymization modules before data sharing.
Operational coverage for the Blockchain Platform targets healthcare research and diagnostic workflows, with an initial pilot tied to the Global Commission created to accelerate diagnostics for children with rare diseases, an initiative co-chaired by Shire. The rollout is being executed as a trial program to evaluate whether the platform can shorten diagnostic timelines, with BlackBerry acting as the implementer and operational steward.
Governance and process changes concentrate on data privacy controls, secure key management, and laboratory integration patterns, reflecting BlackBerry security and compliance priorities. The In-House Blockchain implementation sits alongside BlackBerry Spark for secure IoT, creating an architectural bridge between device endpoint telemetry and auditable, anonymized medical data exchange.
|
|
|
Blackberry | Manufacturing | 1820 | $534M | Canada | OneBio | OneBio Blockchain Platform | Blockchain Platform | 2018 |
In 2018, Blackberry partnered with OneBio to deploy the OneBio Blockchain Platform, a Blockchain Platform solution, to create an ultra-secure distributed ledger for healthcare and medical research. The deployment was designed to store and anonymize patient, laboratory and IoT biometric data and to enable controlled sharing with researchers to accelerate diagnoses.
Configuration emphasized patient data storage and anonymization modules for clinical research, including identity pseudonymization, consented data access controls and immutable audit trails consistent with blockchain ledger features. The OneBio Blockchain Platform was configured to segregate identifiable metadata from research datasets, enabling anonymized dataset assembly for investigators while preserving provenance. Functional capabilities inferred from pilot coverage included data ingestion pipelines for clinical and laboratory records and access control mechanisms for researcher queries.
Integrations focused on ingesting biometric streams from IoT devices and laboratory systems, and on exporting anonymized research datasets to authorized investigator portals. The platform architecture used an ultra-secure ledger layer for provenance and auditability, paired with encryption and anonymization services to separate patient identifiable information from research data. Operational scope targeted global healthcare research collaborations and clinical research teams within Blackberry’s healthcare initiatives starting in 2018.
Governance was implemented around consent management, researcher access workflows and immutable audit logs to support controlled data sharing and compliance-aware research activities. The initial rollout was executed as a pilot for healthcare and medical research use cases in 2018, with module usage centered on patient data storage and anonymization for clinical research.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Buyer Intent: Companies Evaluating Blackberry Services
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||